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Abstract
Background: The expression of leptin is increased in obesity and inhibited by n-3 polyunsaturated fatty acids
(n-3 PUFAs), but the underlying molecular mechanisms have not been firmly established.
Methods: In this study, we investigated the effects of dietary n-3 PUFAs on the methylation of CpG islands in the
promoter regions of the leptin, leptin-R and POMC genes, as well as the effects of n-3 PUFA status in early life on the
modification of the promoters of these three genes. Male C57 BL/6J mice were fed a high-fat diet with one of four
different fat types: sunflower oil (n-3 PUFA deficient), soy oil, fish oil, or a mixture of soy and fish oil (soy:fish oil = 1:1).
Two low-fat diets with sunflower oil or soy oil served as controls. Female mice were fed two breeding diets,
sunflower oil or a mixture of soy and fish oil (soy:fish oil = 1:1), during pregnancy and lactation to breed new pups.
Results: Compared to mice fed the control diets, the expression of leptin in fat tissue and leptin-R and POMC in
the hypothalamus was higher in the diet-induced obesity (DIO) mice, and the n-3 PUFAs in the diets reversed
these elevated expression levels. The mean methylation levels of CpG sites in the promoter regions of the leptin
and POMC genes showed no difference between the DIO and the control diet groups nor between the n-3 PUFA-
containing and -deficient diet groups. For the CpG sites in the promoter regions of leptin-R, no methylation was
found in any of the DIO or control groups. Feeding mice with the n-3 PUFA diet during pregnancy and lactation
did not affect CpG methylation in the leptin or POMC promoters.
Conclusions: Our findings indicate that promoter DNA methylation may not be related to the expression of leptin,
leptin-R or its related hypothalamic satiety regulator POMC.
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Background
Obesity has become a global health epidemic. However,
the molecular etiologies and mechanisms contributing
to obesity have not been well characterized. Epidemiolo-
gical studies have demonstrated that increased n-6
PUFAs and/or decreased n-3 PUFAs in the modern
human diet have been considered to be the risk factors
for the increased prevalence of chronic non-communic-
able diseases in modern society, including obesity,
diabetes, and cardiovascular diseases [1,2]. Supplementa-
tion with fish oil n-3 PUFAs and regular exercise has
been shown to reduce body fat and improve cardiovas-
cular and metabolic health [3]. N-3 PUFAs affect both
adipogenesis in vitro [4] and adipose tissue development
in vivo during the gestation/lactation period. Epidemio-
logical data from infant studies indicate that the fatty
acid composition of fats is an early determinant of
childhood obesity [5].
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obesity is thought to be attributable to their regulation
of physiological processes, such as the synthesis and
oxidation of fatty acids and the differentiation and pro-
liferation of adipocytes, which is mediated by their abil-
ity to modulate gene transcription, messenger RNA
processing and posttranslational protein modifications.
However, n-3 PUFAs have been shown to have different
regulatory roles from n-6 PUFAs [4,6,7]. Results from in
vivo and in vitro studies have demonstrated that n-3
PUFAs are negatively associated with body leptin levels
and reduce the expression of leptin [8-10]. Leptin is pri-
marily produced by adipose tissue, and it has been
shown to regulate food intake and energy expenditure
through a variety of neural and endocrine mechanisms
mediated by the leptin receptor (leptin-R) and its down-
stream satiety regulators, such as orexigenic neuropep-
tide Y (NPY) and anorexigenic pro-opiomelanocortin
(POMC) [11]. In diet-induced obesity (DIO), the con-
centration of circulating leptin is elevated, and this has
been interpreted as an indication of the development of
leptin resistance [12], as are changes in hypothalamic
leptin-R, NPY and POMC [13,14]. In rats and mice, n-3
PUFA supplementation through a high-fat diet reduces
the plasma leptin concentration, leptin mRNA expres-
sion in adipose tissue, and changes the gene expression
of brain satiety regulators [15,16]. Moreover, changing
dietary saturated fat to n-3 PUFAs has been shown to
reverse hyperleptinemia [8,9]. Therefore, n-3 PUFAs
may be involved in leptin resistance in obesity, although
no consistent conclusion has been reached on the
relationships between them [17-19].
More recently, nutrients and other environmental fac-
tors have been shown to induce epigenetic modifications,
such as CpG island methylation and histone modifica-
tions, which, in turn, determine gene silencing versus
expression, leading to susceptibility to many non-com-
municable chronic diseases [20-24]. Some studies have
demonstrated that leptin promoter methylation plays
important roles in leptin expression during pre-adipocyte
differentiation [25,26]. Therefore, we hypothesized that
epigenetic modification of the promoters of leptin, its
receptor and satiety regulators in the hypothalamus may
be the mechanism that causes leptin resistance, and an
imbalanced intake of n-6/n-3 PUFAs (a higher intake of
n-6 PUFAs and a lower intake of n-3 PUFAs) may influ-
ence the epigenetic modification of these promoters in
obesity. In this study, we utilized a high-fat DIO mouse
model to investigate the effects of dietary n-3 PUFAs on
CpG island methylation in the promoter regions of the
leptin, leptin-R and POMC genes. Moreover, based on
emerging data highlighting the possibility that the
epigenetic modulation of gene expression underlies
the early-life programming of an increased risk of
adult-onset diseases [20,21], we determined the effects of
the n-3 PUFA status on the modification of these promo-
ters in the early life of mice and the changes in these
promoters in response to later diet-induced obesity.
Methods
Diets
Based on the high-fat diet formula (D12492) for DIO
mice from Research Diets Inc. (New Brunswick, NJ),
four high-fat diets (34.9% fat by wt., 60% kcal) with dif-
ferent fat types were designed as DIO diets: sunflower
oil (n-3 PUFA deficient), soy oil, fish oil, and a mixture
of soy and fish oil (soy:fish oil = 1:1), by using the same
amount of lard as the main source of fat in each diet,
providing 89% of the total energy from fat. Sunflower
oil was rich in n-6 PUFAs (linoleic acid, LA) (60%-70%)
and deficient in n-3 PUFAs. Soy oil contained small
amount of n-3 PUFAs (a-linolenic acid, ALA) (~10%)
but was still rich in LA (~50%). Fish oil was a rich
source of n-3 PUFAs, especially docosahexaenoic acid
(DHA) and eicosapentaenoic acid (EPA) (30%). As
s h o w ni nT a b l e1 ,t h ea m o u n to fn - 3P U F A sv a r i e d
from a deficiency with the sunflower oil diet to the
highest content with the fish oil diet, accounting for
0.12%, 0.79%, 1.91% and 3.07% of the total fatty acids,
respectively. Meanwhile, two low-fat diets (4.3% fat by
wt., 10% kcal) were also designed as controls - sunflower
oil and soy oil, based on the control diet formula
(D12450B) from Research Diets Inc. In order to investi-
gate the effects of the n-3 PUFA status during both
pregnancy and lactation on leptin promoter methylation
in later life, we made two breeding diets were also
designed: sunflower oil (n-3 PUFA deficient) and a mix-
ture of soy and fish oil (soy:fish oil = 1:1), which were
used to feed pregnant and lactating mice. All the diets
were prepared by the Institute of Laboratory Animal
Sciences at the Chinese Academy of Medical Sciences
and stored at -20°C.
Animals
C57 BL/6J mice (three to four weeks old, both female
and male) were purchased from the Laboratory Animal
Center of the Academy of Military Medical Sciences of
C h i n aa n dh o u s e da tt h ea n i m a l facilities in the Center
under a 12-hour (h) light/12-h dark cycle with cycles of
air ventilation. After one week of recovery from trans-
portation, the mice were fed the experimental diets. For
the DIO experiment, the mice were fed one of the four
DIO diets or one of the two control diets at 17:00 each
day, and the body weight was measured weekly for 12
weeks. To determine the effects of the n-3 PUFA status
i ne a r l yl i f eo nt h em o d i f i cation of the promoters of
these genes later in life, the mice were fed one of the
two types of breeding diets. After 10 weeks of feeding,
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were used for analysis of promoter DNA methylation at
21 days (d) after birth and the other for obesity induction
by feeding n-3 PUFA-deficient DIO diet for 12 weeks. At
the end of each experiment, the fasted mice were anesthe-
tized by intraperitoneal injection of Avertin (2,2,2-tribro-
moethanol) (T-4840-2, Sigma-Aldrich Chemie GmbH,
Steinheim, Germany) (125 mg/kg) to obtain blood samples
by heart puncture. The plasma was stored at -20°C for
later analysis of the leptin levels, and the white blood cells
were used to determine the leptin promoter methylation.
The mice were then sacrificed immediately by decapita-
tion, and the brains and epididymal fat were dissected free
of the surrounding tissue, removed, wrapped in aluminum
f o i la n df r o z e ni nl i q u i dN 2. Once an entire group of
animals was harvested, the tissues were transferred to -80°
C until analysis. All of the animal experiments were
conducted from 08:00 to 12:00 in compliance with the
guidelines of the Animal Care and Use Committee of
Academy of Military Medical Sciences of China.
Analysis of plasma leptin
The plasma leptin concentration was determined by an
enzyme-linked immunosorbent assay kit (Cat. No. ALX-
850-317-KI01, Enzo Life Sci., Plymouth Meeting, PA,
USA), according to the procedures of the manufacturer,
with a detection sensitivity of 0.03 ng/L (intra-assay and
inter-assay CVs of 2.9% and 2.3%, respectively).
Quantitative RT-PCR analysis
Total RNA was extracted from mouse fat and brains
with TRIzol Reagent (Cat. No. 15596-026) (Invitrogen,
Carlsbad, CA, USA), and cDNA was prepared from the
total RNA using the SuperScriptTM III First-Strand
Synthesis System for RT-PCR (Cat. No. 18080-051) kit
(Invitrogen, Carlsbad, CA, USA), according to the pro-
cedures provided. The mRNA levels of leptin, leptin-R,
POMC and NPY in both fat and brains were measured
with real-time quantitative RT-PCR using an ABI
PRISM 7300 sequence detection system (Applied Biosys-
tems, Foster City, CA, USA). The oligonucleotide pri-
mers and probes for leptin, leptin-R, POMC and NPY
were designed and prepared by ABI Applied Biosystems
(Foster City, CA, USA). The co-amplification of mouse
GAPDH mRNA, an invariant internal control, was per-
formed in all of the samples. Assays were performed in
triplicate, and the results were normalized to the
GAPDH mRNA levels by using the 2
ΔΔCT method [27].
Bisulfite conversion and sequencing
The promoter regions of many eukaryotic genes contain
stretches of CpG-rich sequences known as CpG islands.
Percentage of Cs and Gs > 50%, ratio of observed to
expected CG dinucleotides > 0.6 and size of CpG island
sequence > 200 nucleotides were used to define CpG
islands of gene promoters. As shown in Figure 1, the
leptin promoter region examined covers nucleotides
Table 1 Composition of the animal diets
Control DIO
n-3 deficient Soy oil n-3 deficient Soy oil Soy/fish oil Fish oil
Components (g/kg)
Lard 20 20 318 318 318 318
Sunflower oil 25 - 35 - - -
Soy oil - 25 - 35 17.5 -
Fish oil ---- 17.5 35
Fatty acid composistion (% of fat)
Σ Saturated 27.22 28.33 41.83 42.03 43.02 44.01
Σ Momounsaturated 30.67 33.33 41.62 42.82 43.24 42.81
18:2n-6 41.14 32.39 15.51 13.36 10.65 8.59
20:4n-6 0.97 1.05 0.94 0.7 0.58 0.62
22:4n-6 - - - 0.3 0.6 0.9
Σ n-6 PUFAs 42.11 34.44 16.55 14.36 11.83 10.11
18:3n-3 0.09 3.89 0.12 0.79 0.17 0.11
20:5n-3 ---- 1.02 1.85
22:6n-3 ---- 0.72 1.11
Σ n-3 PUFAs 0.09 3.89 0.12 0.79 1.91 3.07
Total energy (kcal%)
Fat 10 10 60 60 60 60
Protein 20 20 20 20 20 20
Carbohydrate 70 70 20 20 20 20
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-324 to -29 (positions are given with respect to the tran-
scription start site [TSS]). The leptin-R promoter region
examined spans nts 101389512-101390511 and includes
18 CpGs within nts -633 to -345 (with respect to the
TSS). The POMC promoter region examined spans nts
3954450-3955047 and includes 14 CpGs within nts -451
to -167 (with respect to the TSS). These sequence data
have been submitted to the GenBank databases (http://
www.ncbi.nlm.nih.gov) under accession number U18812,
U46135 and NC_000078.5 respectively.
The promoter methylation of the leptin, POMC and
NPY genes was analyzed by bisulfite sequencing. A
DNA Purification Kit (Cat. No. DN 1008, Biofuture
Group Inc, Beijing, China) was used to isolate and purify
DNA from the adipose and brain tissue. Bisulfite con-
version was performed using the MethylampTM DNA
Modification Kit (Cat. No. P-1001, Epigentek Group Inc.
Brooklyn, NY). Converted DNA was used fresh, or it
w a ss t o r e da t- 2 0 ° C .C o n v e r t e dD N Aw a sa m p l i f i e db y
nested-PCR using Taq DNA Polymerase Master Mix
(Cat. No. KT201, Tiangen Biotech Inc., Beijing, China)
and primer sets (Table 2) designed using Methprimer
software (http://www.urogene.org/methprimer/index1.
html). For leptin, the PCR conditions were 96°C for 10
minutes (min) and 45 cycles of 96°C for 1 min, 51°C for
1 min and 72°C for 1 min, followed by 10 min at 72°C.
For leptin-R, the PCR conditions were 96°C for 10 min
and 45 cycles of 96°C for 1 min, 55°C for 1 min and 72°
C for 1 min, followed by 10 min at 72°C. For POMC,
the PCR conditions were 96°C for 10 min and 45 cycles
of 96°C for 1 min, 51°C for 1 min and 72°C for 1 min,
followed by 10 min at 72°C. Nested PCR was performed
for all three genes with the same conditions as the first
step PCR. The PCR products were sequenced directly,
and DNA methylation was calculated as described by
Lewin et al [28].
Statistical analysis
One-way analysis of variance (ANOVA) was used to
compare the means in different groups using SPSS Ver-
sion 11.5 for Windows. All of the values were expressed
as means ± S.D. Significant differences in leptin expres-
sion between the DIO group and the low-fat diet groups
were assessed using the Student-Newman-Keuls test,
and comparisons between the n-3-deficient DIO group
and the n-3 PUFA-containing DIO groups were deter-
mined by Dunnett’s test. For unequal variances, the
Games-Howell and Dunnett’sT 3t e s t sw e r eu s e dt o
compare the differences. The Binomial test was used for
comparison of DNA methylation levels.
Results
Changes in body weight and plasma leptin
concentrations in DIO mice
After 12 weeks of feeding, the body weight in all the
DIO diet groups was significantly higher than that in
the control diet groups (P < 0.05). If the four DIO diet
groups were compared, the body weight was lower with
Figure 1 Regions of the mouse leptin, leptin-R and POMC
promoters. The CG dinucleotides are underlined and letters (a to r)
were assigned to each of the analyzed CGs. (A) The leptin promoter
sequence with CpG islands spanning nucleotides -324 to -29. (B)
The leptin-R promoter sequence with CpG islands spanning
nucleotides -633 to -345. (C) The POMC promoter sequence with
CpG islands spanning nucleotides -451 to -167.
Table 2 Bisulfite sequencing primers used in this study
Gene name Forward (F) and Reverse (R) Primers Product
size (bp)
Leptin 310
Outer F: 5’-GAGTAGTTAGGTTAGG
TATGTAAAGAG-3’
Inner F: 5’-AGTTTTTTGTAGTTTTTTGTT
TTTTG-3’
R: 5’-TAATAACTACCCCAATACC
ACTTAC-3’
Leptin-R 294
F: 5’-TGTAAAGGTTAGAGAGGAT
AGAATTAG-3’
Outer R: 5’-
CTTATATCTTTCAAACCAACCCACCCT-3’
Inner R: 5’-CCAATCTACTACCTAAT
CCCCAAAC-3’
POMC 258
Outer F: 5’-TTGTAAGATTTTAGAA
TTAGGTTTG-3’
Inner F: 5’-AGTTTTTGTTTAGTTTTAAG
TGGAG-3’
R: 5’-CTCTCTTCTTTTATACTTACAA
AATTAAA-3’
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PUFA-deficient diet (P < 0.05). For food intake, differ-
ences were found among the DIO and control diet
groups, showing higher energy intake with all the DIO
diets than the control diets and lower energy intake
with n-3 PUFA-containing DIO diets compared to n-3
PUFA-deficient DIO diet groups (P < 0.05). Plasma lep-
tin concentrations were higher in all of the four groups
of mice fed the DIO diets as compared with the mice
fed the control diets (P < 0.05). Comparisons among the
n-3 PUFA-deficient DIO diet and the n-3 PUFA-
containing DIO diets showed that all the three n-3
PUFA-containing diets had lower levels of plasma leptin
concentration. However, the difference was only shown
between the fish oil DIO diet and the n-3 PUFA-
deficient DIO diet (P < 0.05) (Table 3).
Effects of n-3 PUFAs on the gene expression of leptin,
leptin-R, POMC and NPY in DIO mice
As shown in Figure 2, compared to the n-3-deficient
and soy oil diet groups, the mRNA expression levels of
leptin, leptin-R and POMC were higher (P < 0.05), and
that of NPY was lower, only in the n-3-deficient DIO
diet group (P < 0.05); no changes occurred in the other
three n-3 PUFA-containing DIO diet groups. These
results indicate that the addition of n-3 PUFAs to diets
reverses both the increased expression of leptin, leptin-R
and POMC and the decreased expression of NPY.
Effects of n-3 PUFAs on the methylation of CpG
islands in the promoters of the leptin, leptin-R
and POMC genes in DIO mice
The mean methylation level of the 16 and 14 CpG sites
in the promoter regions of the leptin and POMC genes
ranged from 72% to 77% and 69% to 71%, respectively,
and showed no significant differences between the DIO
and the control mice (Table 4 and Table 5). However,
an increased methylation level was indicated in many
CpG sites of the leptin promoter in DIO mice compared
to the control mice. Furthermore, the n-3 PUFA-
containing diets seemed to reduce the methylation level
of leptin promoter in DIO mice. For the 18 CpG sites in
the promoter region of leptin-R, no methylation was
found in any of the DIO or control groups.
Table 3 Changes in body weight, food intake and plasma leptin concentration in DIO mice
Control DIO
n-3 deficient Soy oil n-3 deficient Soy oil Soy/fish oil Fish oil
Body weight (g) 27.69 ± 1.38 27.28 ± 1.14 34.73 ± 2.75 * 32.06 ± 2.16 *
‡ 32.86 ± 1.96 *
‡ 32.15 ± 1.89 *
‡
Leptin (μg/L) 1.39 ± 0.98 1.54 ± 1.13 8.55 ± 2.39 * 5.95 ± 3.34 * 6.79 ± 3.28 * 4.39 ± 2.09 *
‡
Energy intake (kcal/d/mouse)
¶ 23.15 ± 2.59 22.99 ± 1.48 35.17 ± 3.89 * 31.37 ± 2.62 *
‡ 32.11 ± 3.17 *
‡ 29.54 ± 2.77 *
‡
3-4 week old C57BL/6J male mice were fed four DIO diets with different fat types and the control diet for 3 months.
¶ Food intake was recorded at 6 weeks.
Values are means ± SD, n = 15 in each group. * compared to the control diets, P < 0.05;
‡ compared to the n-3 deficient DIO diet, P < 0.05.
Figure 2 The effects of n-3 PUFAs on the mRNA expression of
leptin, leptin-R, POMC and NPY in DIO mice. Male C57BL/6J mice,
3-4 weeks old, were fed one of four DIO diets with different fat types
or a control diet for 3 months. Real-time quantitative RT-PCR was used
to measure the mRNA levels of leptin in epididymal fat and those of
leptin-R, POMC and NPY in the hypothalamus. The data were
normalized to GAPDH mRNA levels using the 2
ΔΔCT method. Values are
means ± SD, n = 15 in each group. * compared to the control diets, P
<0 . 0 5 ;
‡ compared to the n-3 deficient DIO diet, P < 0.05.
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the promoters of the leptin, leptin-R and POMC genes in
early life and their changes in later diet-induced obesity
For 21-day-old mice fed the n-3 PUFA-containing diet
during maternal pregnancy and lactation, the mean
methylation levels of 16 and 14 CpG sites in the promo-
ter regions of the leptin and POMC genes (88% and
70%), respectively, did not change, as compared to those
in the n-3 PUFA-deficient diet group (86% and 69%).
Moreover, after three months of obesity induction, the
mean methylation levels of the CpG sites in the promo-
ter regions of the leptin and POMC genes did not show
any differences between the n-3 PUFA-deficient diet
(83% and 65.2%) and n-3 PUFA-containing diet groups
(81% and 65.1%). For the 18 CpG sites in the promoter
region of the leptin-R gene, no methylation was found
in any of the DIO or control groups.
Discussion
In the present study we found that the expression of
leptin in DIO mice was higher than in low-fat fed mice,
and the addition of n-3 PUFAs to the diet reduced the
expression of leptin. Moreover, we found that DIO mice
had higher mRNA expression levels of leptin-R and
POMC and lower expression levels of NPY, and the
expression of all three of the genes was normalized by
adding n-3 PUFAs to the diet. It has been found that n-
3 PUFA supplementation in high-fat diets fed to rats
and mice reduces the plasma leptin concentration and
leptin mRNA expression in adipose tissue, and changing
the dietary saturated fat to n-3 PUFAs reverses hyper-
leptinemia [8,9,29], which agrees with our results. In
contrast, increased leptin expression in response to n-3
PUFAs has also been reported in rodents and in primary
cultured rat adipocytes [17,18].S t i l l ,n oc o n s i s t e n tc o n -
clusion has been reached of the effects of n-3 PUFAs on
the expression of leptin-R and its related neuropeptides
in obesity. The hypothalamus leptin-R expression in
DIO rodents is increased with either shorter feeding
periods (6 to 7 weeks) or longer feeding periods (19
weeks) [9,15], whereas the expressions of POMC and
NPY vary with increase, reduction or no change inde-
pendent of the feeding duration [9,15,16,30]. All these
discrepancies need to be clarified, although they are
Table 4 Quantitative methylation analysis of the promoter region of the leptin gene
Diets CpG site (position) Total
abcdefghi jklmnop
DIO
n-3 deficient 66 80 63 71 80 68 78 83 67 80 77 81 82 78 89 93 77
Soy oil 65 78 63 69 79 68 80 83 66 78 79 81 82 81 90 95 77
Soy/Fish oil 62 78 62 68 77 66 78 82 65 76 76 79 81 79 89 96 76
Fish oil 63 75 61 66 75 66 77 82 64 76 76 79 80 78 88 93 75
Control
n-3 deficient 58 69 57 65 74 61 75 80 67 71 70 74 78 74 88 93 72
Soy oil 60 73 56 64 72 63 74 78 63 73 73 77 80 78 87 94 73
3-4 weeks old C57BL/6J male mice were fed four DIO diets with different fat types and the control diet for 3 months. Genomic DNA isolated from epididymal fat was
analyzed for methylation status of 16 CpG sites at the indicated positions of the leptin gene promoter spanning nucleotides from -324 to -29 relative to transcription
start site. Data for each CpG site represent the mean percentage level (0% = nonmethylated, 100% = methylated) determined from 15 mice in each group.
Table 5 Quantitative methylation analysis of the promoter region of the POMC gene
Diets CpG site (position) Total
abcdefghi jklmn
DIO
n-3 deficient 81 80 61 71 75 81 80 47 50 75 63 63 71 73 69
Soy oil 80 80 61 73 78 83 81 48 48 77 67 65 75 76 71
Soy/Fish oil 81 81 62 73 78 82 81 48 49 75 64 62 72 73 70
Fish oil 78 77 57 71 79 83 82 45 52 76 56 65 73 75 69
Control
n-3 deficient 80 80 61 72 78 81 80 47 50 76 65 63 73 73 70
Soy oil 78 78 58 70 78 81 81 46 49 76 64 65 74 75 70
3-4 week old C57BL/6J male mice were fed four DIO diets with different fat types and the control diet for 3 months. Genomic DNA isolated from epididymal fat
tissue was analyzed for methylation status of 14 CpG sites at the indicated positions of the POMC gene promoter spanning nucleotides -660 to -53 relative to
transcription start site. Data for each CpG site represent the mean percentage level (0% = nonmethylated, 100% = methylated) determined from 15 mice in each
group.
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status (fed or fasted), the period of obesity induction as
well as fluctuations with diurnal rhythm [9,15,16,30].
The homeostatic response of POMC and NPY mRNA
expressions to the high leptin levels in the DIO diet
groups should then, at least as one important factor,
have been associated with satiety and have worked to
normalize weight (and fat) gain. In this study, food
intake was increased in DIO diet groups although
POMC and NPY mRNA expressions were increased and
reduced respectively with DIO diet feeding, compared
with the control diets. This suggests that the response
of POMC and NPY expressions in DIO mice is insuffi-
cient to maintain energy homeostasis. If this response
lasts for a longer period, leptin resistance may occur. As
far as the effects of fat type concerned, in this study,
introduction of n-3 PUFAs to DIO diets reversed the
abnormal expressions of the above genes, accompanying
reduced energy intake and body weight. This is in keep-
ing with many other reports demonstrating that supple-
menting the diet with n-3 PUFAs can attenuate weight
gain and reduce body fat by altering gene expression in
a range of tissues that favour increased fat oxidation
and reduced fat deposition, and reductions in food
intake and apoptosis of adipocytes [31].
The mechanisms underlying the abnormal expression
of these genes and the regulatory roles of n-3 PUFAs
are complicated and multiple, and they are still far from
being fully understood. Several lines of evidence have
suggested that the expression of genes controlling
energy homeostasis could be regulated by epigenetic
mechanisms, which may play a role in the development
of obesity [32,33]. Recent studies have demonstrated
that leptin promoter methylation plays important roles
in leptin expression. In vivo studies in humans and mice
have indicated that leptin promoter methylation is nor-
mally imposed during postzygotic development, and that
this epigenetic mark may function in modulating the
leptin expression [26]. Melzner et al. reported that
CpGs in the proximal leptin promoter were highly
methylated in pre-adipocytes, and during maturation
toward terminally differentiated adipocytes, this promo-
ter region was found to be highly demethylated [25].
This suggests that the methylation of CpGs inhibits lep-
tin expression, whereas their demethylation activates
leptin expression.
Very recently, Milagro et al. reported that high-fat
diet-induced obesity modifies the methylation pattern of
the leptin promoter in rats, although only one CpG site
was slightly methylated [34]. However, Okada et al. have
demonstrated that the diet-induced up-regulation of lep-
tin expression was not mediated by changes of the
methylation of its promoter [35]. In the present study, a
declining trend was shown in the level of leptin
promoter methylation in DIO mice as compared with
low-fat control mice and the addition of n-3 PUFAs to
the diets seemed to reduce the level of leptin promoter
methylation, although the significant difference was not
reached statistically. Whether this is attributable for
shorter feeding periods (12 weeks) in our study needs to
be clarified by inducing DIO mice for longer feeding
periods in the future. However, no changes were found
for the methylation of the leptin-R and POMC promo-
ters in DIO mice, and dietary n-3 PUFA supplementa-
tion did not affect the promoter methylation of these
genes. In addition, we also tested the leptin promoter
methylation in peripheral blood cells in obese preschool
c h i l d r e na n df o u n dn oc h a n g e s ,a sc o m p a r e dt ol e a n
children (unpublished data). Taken together, our find-
ings indicate that the transcriptional regulation of leptin,
leptin-R and POMC by n-3 PUFAs in DIO mice is not
associated with the methylation of their promoters.
Extensive human epidemiological data have indicated
that nutrition during critical periods of development can
influence adult susceptibility to non-communicable
chronic diseases, and the underlying mechanisms are
defined as epigenetic modifications that determine gene
silencing versus expression [20-24]. Changes in leptin
expression during perinatal life are associated with adult
leptin resistance and adipogenic and diabetogenic phe-
notypes. Moreover, leptin treatment in adult female rat
offspring that were born following maternal undernutri-
tion failed to reduce the food intake, and weight loss
was diminished compared with leptin-treated offspring
of dams fed ad libitum throughout pregnancy. These
results suggest that prenatal nutrition can shape future
susceptibility to obesity through alterations in leptin
sensitivity and changes in energy metabolism during
adult life [36,37]. Moreover, the manipulation of the
postnatal diet has been shown to limit the adverse out-
comes of fetal programming, as a postnatal diet enriched
with n-3 fatty acids prevented pre-programmed hyper-
leptinemia and hypertension [5,38]. To investigate
whether the status of n-3 PUFAs in early life affected
the methylation status of the leptin, leptin-R or POMC
promoters, we fed mice with the diets rich in n-3
PUFAs during pregnancy and lactation, and no changes
were observed in the promoter methylation levels of
these three genes in the offspring at the age of infancy
and adulthood.
Recently, much attention has been focused on histone
modifications because of their critical role in regulating
gene expression and their active involvement in a num-
ber of cellular processes, such as mitosis and cellular
differentiation [39]. Histone H3 and H4 hyperacetylation
in promoter regions is associated with gene activation in
organisms ranging from yeast to mammals, and tran-
scriptionally active euchromatin regions are highly
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Page 7 of 9enriched in acetylated histones, whereas histone methy-
lation can have both positive and negative effects on
transcription, depending on the site of methylation
[40-42]. Recent studies have revealed that changes in
histone modifications are a key component of an epige-
netic network controlling adipogenesis and energy
homeostasis. Studies of the role of epigenetic histone
modifications in human nutrition and obesity will be a
fruitful area for further research [32,43,44].
Conclusion
To summarize, our findings indicate that promoter DNA
methylation does not contribute directly to the changes
in the expression of leptin, leptin-R or its related
hypothalamic POMC. More detailed studies of the epige-
netic changes associated with leptin resistance in obesity
are warranted to gain insight into the link between n-3
PUFAs and obesity. Histone modifications in the promo-
ters of leptin, leptin-R and its related satiety regulators
will be important to elucidate the regulatory influence of
n-3 PUFAs on leptin expression in obesity.
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